Nitric oxide synthase inhibitors produce phencyclidine-like behavioral effects in pigeons

被引:22
作者
Jewett, DC [1 ]
Butelman, ER [1 ]
Woods, JH [1 ]
机构
[1] UNIV MICHIGAN,DEPT PSYCHOL,ANN ARBOR,MI 48109
关键词
phencyclidine; nitric oxide; N omega-nitro-L-arginine methyl ester; 7-nitroindazole; discriminative stimulus; drug discrimination; operant behavior; catalepsy;
D O I
10.1016/0006-8993(95)01328-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The present study assessed the ability of nitric oxide synthase (NOS) inhibitors to produce PCP-like behavioral effects in pigeons. Food-restricted pigeons were trained to discriminate between PCP (1.0 mg/kg, i.m.) from saline in a two-key operant procedure. NOS inhibitors 7-nitroindazole (7-NI) and N-omega-nitro-L-arginine methyl ester (L-NAME) produced PCP like discriminative stimulus effects. 7-NI (17.8 mg/kg, i.m.) completely generalized to PCP. L-NAME (320-1000 mg/kg) produced partial generalization to PCP. D-NAME, the enantiomer of L-NAME, did not produce PCP-appropriate behavior. L-NAME was approximately 200-times more potent i.c.v., but did not fully generalize to PCP. Both NOS inhibitors were effective in producing catalepsy, which is an effect commonly produced by competitive and uncompetitive NMDA antagonists. 7-NI (32 mg/kg) produced catalepsy in all subjects, whereas L-NAME (3200 mg/kg) produced catalepsy in 50% of the subjects. D-NAME did not produce catalepsy. Pretreatment with L-arginine (32-3200 mg/kg) prevented the PCP-like discriminative stimulus and cataleptic effects of 7-NI (17.8-32 mg/kg), demonstrating that 7-NI produced PCP-like effects through blockade of NO synthesis. The current studies reveal that NOS inhibitors induced two behavioral actions, discriminative stimulus effects and catalepsy, that are very selective for NMDA antagonists in pigeons.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 38 条
[1]   ANTINOCICEPTIVE ACTIVITY OF NITRIC-OXIDE SYNTHASE INHIBITORS IN THE MOUSE - DISSOCIATION BETWEEN THE EFFECT OF L-NAME AND L-NMMA [J].
BABBEDGE, RC ;
HART, SL ;
MOORE, PK .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1993, 45 (01) :77-79
[2]   ALTERED SYNAPTIC PLASTICITY AND MEMORY FORMATION IN NITRIC-OXIDE SYNTHASE INHIBITOR-TREATED RATS [J].
BOHME, GA ;
BON, C ;
LEMAIRE, M ;
REIBAUD, M ;
PIOT, O ;
STUTZMANN, JM ;
DOBLE, A ;
BLANCHARD, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (19) :9191-9194
[3]   NITRIC-OXIDE MEDIATES GLUTAMATE-LINKED ENHANCEMENT OF CGMP LEVELS IN THE CEREBELLUM [J].
BREDT, DS ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :9030-9033
[4]  
BUTELMAN ER, 1991, BEHAV PHARMACOL, V2, P79
[5]  
CHEN G, 1965, ARCH INT PHARMACOD T, V157, P193
[6]  
CHOI DW, 1988, J NEUROSCI, V8, P185
[7]  
Ferster CB., 1957, Appleton-Century-Crofts
[8]   INTRACEREBROVENTRICULAR DRUG ADMINISTRATION IN PIGEONS [J].
FRANCE, CP ;
ADAMS, JU ;
WOODS, JH .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1985, 23 (05) :731-736
[9]  
FRANCE CP, 1990, J PHARMACOL EXP THER, V255, P1271
[10]  
FRANCE CP, 1989, J PHARMACOL EXP THER, V250, P197